Article Abstract

Resistance patterns to anti-PD-1 therapy in metastatic melanoma

Authors: Alpaslan Ozgun, Vernon K. Sondak, Joseph Markowitz

Abstract

Anti-PD-1 antibodies block the immune checkpoint programmed death 1 receptor to increase T cell specific anti-tumor responses (1,2).

Refbacks

  • There are currently no refbacks.